JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China

JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China. JW Therapeutics, a joint venture between Juno and WuXi AppTec, raised $300 million in its IPO on the Hong Kong Stock Exchange — building on $190 in venture money since launching in 2018.